- ►diabetesjournals.org [PDF] VA Fonseca, J Rosenstock, AC Wang, KE … - Diabetes Care, 2008 - Am Diabetes Assoc Page 1. Colesevelam Improves Glucose and Lipid Levels Colesevelam HCl Improves
Glycemic Control and Reduces LDL-Cholesterol in Patients ... Cited by 3 - Related articles - All 3 versions
[CITATION] Efficacy and safety of colesevelam hydrochloride in patients with type 2 diabetes mellitus …
- ►nih.gov - Free from Publisher VA Fonseca, J Rosenstock, AC Wang, KE … - Diabetes care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A 26-week, randomized, double-blind,
placebo-controlled, parallel-group, multicenter study was carried out between
August 2004 and August 2006 to evaluate the efficacy and safety of ... Cited by 16 - Related articles - All 5 versions
NJ Parsippany - Am Diabetes Assoc 1 Corresponding author: Tulane University Health Sciences Center, 1430 Tulane
Avenue – SL 53, New Orleans, LA 70112, Email: vfonseca@tulane.edu; 2Dallas
Diabetes and Endocrine Center, Dallas, TX; 3Daiichi Sankyo Pharma ... Related articles
[CITATION] Cardiovascular outcomes by glycemic control treatment arm
WC Duckworth - Glycemic Control and Cardiovascular Outcomes—the VA …, 2008 Cited by 2 - Related articles
AD Bagchi, D Esposito, JM Verdier - Health care financing review, 2007 - ncbi.nlm.nih.gov Using Medicaid Analytic eXtract (MAX) claims files for 1999 and 2001, the
authors describe patterns of prescription drug use and expenditures among dually
eligible Medicare and Medicaid beneficiaries for all Medicaid full dually ... Cited by 2 - Related articles - BL Direct
- ►oxfordjournals.org DJ Betteridge - European Heart Journal Supplements, 2004 - Eur Soc Cardiology Cardiovascular disease (CVD) is a major cause of morbidity and mortality in
patients with type 2 diabetes. Individuals with diabetes are at a much greater
risk of developing CVD than those without diabetes, and have a much poorer ... Cited by 4 - Related articles - All 3 versions
T Teramoto, N Yamada, K Shirai, Y Saito - Journal of atherosclerosis and thrombosis, 2007 - ncbi.nlm.nih.gov AIM: The effects of pioglitazone hydrochloride monotherapy on abnormal lipid
control were evaluated in Japanese patients with type 2 diabetes mellitus,
comparing with glibenclamide monotherapy. METHODS: Patients were randomly ... Cited by 4 - Related articles - BL Direct
AB Goldfine - Current opinion in cardiology, 2008 - journals.lww.com Purpose of review: Individuals with type 2 diabetes mellitus (T2DM) have a
number of potentially modifiable risk factors, including dyslipidemia,
hypertension, and hyperglycemia, that contribute to coronary artery disease ... Cited by 5 - Related articles - All 3 versions
